Literature DB >> 22865134

The role of pain management in recovery following trauma and orthopaedic surgery.

Chester C Buckenmaier1.   

Abstract

War often serves as a catalyst for medical innovation and progressive change. The current conflicts are no exception, particularly in the area of pain management of wounded warriors. Morphine administration has served as the primary method of battlefield pain management since the American Civil War. Although traditional opioid-based pain management is effective, it has significant side effects that can complicate recovery and rehabilitation following injury. These side effects (eg, sedation, nausea and vomiting, ileus, respiratory depression) can be fatal to persons wounded in combat. This fact, along with recent research findings indicating that pain itself may constitute a disease process, points to the need for significant improvements in pain management in order to adequately address current battlefield realities. The US Army Pain Management Task Force evaluated pain medicine practices at 28 military and civilian institutions and provided several recommendations to enhance pain management in wounded warriors.

Entities:  

Mesh:

Year:  2012        PMID: 22865134     DOI: 10.5435/JAAOS-20-08-S35

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  3 in total

1.  Evaluation of controlled prescriptions with a diagnosis of surgical intervention.

Authors:  Ahmet Akıcı; Mustafa Ümit Uğurlu; İbrahim Topçu; Hüseyin Yılmaz; Dilek Demircan
Journal:  Ulus Cerrahi Derg       Date:  2013-03-01

Review 2.  Interdisciplinary Mitigation of Opioid Misuse in Musculoskeletal Patients.

Authors:  Ammar N Saigal; Henderson M Jones
Journal:  HSS J       Date:  2018-12-10

3.  Predictors of Veterans Health Administration utilization and pain persistence among soldiers treated for postdeployment chronic pain in the Military Health System.

Authors:  Rachel Sayko Adams; Esther L Meerwijk; Mary Jo Larson; Alex H S Harris
Journal:  BMC Health Serv Res       Date:  2021-05-24       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.